Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SOS1 inhibitors(Son of sevenless homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS mutation-related tumors | IND Approval | CN | 28 Apr 2024 | |
Solid tumor | Preclinical | CN | 21 Aug 2023 |